Short Interest in RenovaCare, Inc. (OTCMKTS:RCAR) Decreases By 76.8%

RenovaCare, Inc. (OTCMKTS:RCAR) was the recipient of a significant decrease in short interest in the month of August. As of August 31st, there was short interest totalling 7,200 shares, a decrease of 76.8% from the August 15th total of 31,000 shares. Based on an average trading volume of 40,500 shares, the days-to-cover ratio is presently 0.2 days.

Shares of OTCMKTS:RCAR traded up $0.03 during midday trading on Thursday, reaching $1.06. The company’s stock had a trading volume of 2,501 shares, compared to its average volume of 15,360. The firm has a market capitalization of $92.59 million, a PE ratio of -13.25 and a beta of 2.31. RenovaCare has a twelve month low of $0.70 and a twelve month high of $3.98. The stock has a fifty day moving average of $1.51 and a 200 day moving average of $2.14.

RenovaCare (OTCMKTS:RCAR) last released its quarterly earnings results on Tuesday, August 3rd. The biotechnology company reported ($0.01) EPS for the quarter.

About RenovaCare

RenovaCare, Inc operates as a development stage company, which focuses on research, development, and commercialization of autologous cellular therapies that can be used for medical and aesthetic applications. Its flagship technology is the CellMist System, which is comprised of a treatment methodology for cell isolation for the regeneration of human skin cells and other tissues; and a solution sprayer device for delivering cells to the treatment area.

See Also: CBOE Russell 2000® Volatility Index

Receive News & Ratings for RenovaCare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RenovaCare and related companies with MarketBeat.com's FREE daily email newsletter.